semaglutide clinical trial weight loss drug Wegovy helps people with common type of heart failure, finds Semaglutide 2.4 mg – New

38 DPP-4 inhibitors should not be prescribed together with GLP-1RAs, as the combined incretin therapy has no significant synergistic effects and is not cost effective

J Am Acad Dermatol 37(4):575577

Circadian control of the NAD + salvage pathway by CLOCK-SIRT1

They might suggest writing down what you eat or doing tests to figure out the problem

Previous research has shown that, among gut bacteria, the abundance of Lachnospira and Clostridium were significantly high in IBS patients (Zhuang et al., 2018), and Clostridium difficile has been shown to increase the risk of post-infectious IBS (Piche et al., 2007

In the U.S., Lilly will compete with Novo's newly launched Wegovy pill